Press release
Therapeutic Proteins Global Market Report 2024 Market Overview 2024-2033 - Share, Size, Insights, Forecast"
Therapeutic Proteins Global Market Report
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=2555&type=smp
According to The Business Research Company's, The therapeutic proteins market size has grown rapidly in recent years. It will grow from $140.96 billion in 2023 to $158.16 billion in 2024 at a compound annual growth rate (CAGR) of 12.2%. The growth in the historic period can be attributed to advances in protein engineering, expansion into chronic diseases, advent of immunotherapy, development of recombinant dna technology, targeted cancer therapies.
The therapeutic proteins market size is expected to see rapid growth in the next few years. It will grow to $257.4 billion in 2028 at a compound annual growth rate (CAGR) of 12.9%. The growth in the forecast period can be attributed to regulatory adaptations, enhanced delivery systems, gene editing integration, biobetters development, immunotherapy evolution. Major trends in the forecast period include regulatory framework enhancements, improved delivery systems, biotechnology advancements, personalized medicine, monoclonal antibodies dominance.
Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/therapeutic-proteins-global-market-report
Market Drivers and Trends:
The therapeutic proteins market is being driven by technological advancements in protein-based drug development. Therapeutic proteins cannot be synthesized chemically, they need to be produced by genetic engineering and recombinant DNA technology in living cells or organisms. Protein-engineering platform technologies such as glycoengineering, pegylation, Fc-fusion, albumin fusion, and albumin drug conjugation help to increase the production yield, product purity, circulating half-life, targeting, and functionality of therapeutic proteins drugs. Belimumab, ipilimumab, taliglucerase alfa, albiglutide, and recombinant human coagulation factor IX are some therapeutic proteins drugs developed using protein engineering technologies and approved by the FDA in the past five years.
Monoclonal antibody drug approvals are increasing in the protein therapeutic segment. Chronic diseases such as cancer and immunological disorders are well treated with monoclonal antibodies. Monoclonal antibodies are a dominant and well-established product class in the protein therapeutic segment, with more safety and immunogenicity than antibodies. By overcoming the problems associated with previous antibody drugs, cell-based expression systems, such as the Chinese hamster ovay (CHO) mammalian cell expression system, have increased the productivity of monoclonal antibodies. In the last five years, the FDA has approved 213 drugs, among which 44 are monoclonal antibodies. For instance, twelve monoclonal antibodies were approved by FDA for the treatment of cancer and immunological disorders.
Key Benefits for Stakeholders:
• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.
Major Key Players of the Market:
Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Novartis International AG, Sanofi S.A, Bristol Myers Squibb Co., AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Amgen Inc., Novo Nordisk A/S, Baxter International Inc., Teva Pharmaceutical Industries Ltd., CSL Behring LLC, Chugai Pharmaceutical Co. Ltd., Biogen Inc., Kyowa Kirin Co. Ltd., Oramed Pharmaceuticals Inc., Sandoz International GmbH, Hualan Biological Engineering Inc., Genentech Inc., ProBiogen AG, Diasome Pharmaceuticals Inc., Generx Biotechnology Corp., GeneScience Pharmaceuticals Co. Ltd.
Therapeutic Proteins Market 2024 Key Insights:
• The therapeutic proteins market size is expected to see rapid growth in the next few years. It will grow to $257.4 billion in 2028 at a compound annual growth rate (CAGR) of 12.9%.
• Technological Advancements Fueling The Growth Of The Therapeutic Proteins Market
• Rising Approvals Of Monoclonal Antibody Drugs In Protein Therapeutics
• North America was the largest region in the therapeutic proteins market in 2023
We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/Customise?id=2555&type=smp
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Therapeutic Proteins Global Market Report 2024 Market Overview 2024-2033 - Share, Size, Insights, Forecast" here
News-ID: 3778063 • Views: …
More Releases from The Business research company
Surge in the Carbon Fiber Prepreg Market: Insights, Key Players, and Trends Driv …
Emerging Growth Opportunities in the Global Carbon Fiber Prepreg Market as the Projected Worth Expected to Reach $11.45 Billion in 2025
What Is The Projected Market Size Of The Global Carbon Fiber Prepreg Market And Its Growth Rate?
The Carbon Fiber Prepreg market has shown impressive growth recently and is projected to continue this positive trend. Specific data includes:
- The market size is projected to grow from $10.43 billion in 2024 to…
Global Boiler Insurance Market: Swift Growth and Prospects for 2024-2025
Explosive CAGR of 15.4%, fueled by industrial expansion, extensive boiler installations, risk mitigation, and preventive maintenance.
What Is The Projected Market Size Of The Global Boiler Insurance Market And Its Growth Rate?
The boiler insurance market has experienced rapid growth in recent years, and is projected to grow from $12.18 billion in 2024 to $14.06 billion in 2025 at a compound annual growth rate (CAGR) of 15.4%. Key factors include:
• Industrial growth…
Surging Growth in Baby Carriers Market: From $0.93 billion in 2024 to $0.97 bill …
Expect significant developments in the baby carriers market with rising safety, comfort, product innovation, and rising birth rates driving the growth in the market.
What is the Projected Market Size of the Global Baby Carriers Market and its Growth Rate?
The baby carriers market has seen steady growth in recent years. It has grown:
• From $0.93 billion in 2024
• To $0.97 billion in 2025
• At a compound annual growth rate (CAGR) of…
Automotive Electric Water Pump Market: Accelerated Growth Rate, Key Drivers, and …
Fueled by advancements in emission reduction and smart cooling systems, the automotive electric water pump market size is set to reach $4.38 billion in 2025 and further grow to $7.6 billion in 2029 with a CAGR of 14.8%.
What Is The Projected Market Size Of The Global Automotive Electric Water Pump Market And Its Growth Rate?
The automotive electric water pump market has been displaying rapid growth in recent years and is…
More Releases for Therapeutic
HOME THERAPEUTIC EQUIPMENT INDUSTRY OUTLOOK 2022
The global home therapeutic equipment market is projected to grow from USD 11.06 billion in 2018 to USD XX.XX billion by 2030, at a CAGR of 5.5% during the forecast period. The growth of this market can be attributed to the increasing prevalence of chronic diseases, the rising geriatric population, and the growing demand for home healthcare services.
Get free copy of the report 2022: https://www.accuracyreports.com/request/download/12/11431/Global-Home-Therapeutic-Equipment-Industry-Outlook-2022:-Overview-Opportunities-Key-Companies-and-Forecast-to-2028
This report studies the Home Therapeutic…
Recombinant Therapeutic Antibodies and Proteins Market continues to expand with …
Recombinant therapeutic protein drugs are an important class of medicines, which helps patients in need of novel therapies. Recently approved recombinant protein therapeutics have been developed to treat a wide variety of clinical indications, including cancers, inflammation/autoimmunity, genetic disorders, and exposure to infectious agents. The latest advancements in protein-engineering technologies have allowed drug manufacturers and developers to adjust desirable functional characteristics of proteins of interest maintaining product efficacy. Protein-based therapies…
Therapeutic Vaccine Market 2020 - 2028 Top Companies Agenus Inc., Argos Therapeu …
This detailed market study covers therapeutic vaccine market growth potentials which can assist the stake holders to understand key trends and prospects in therapeutic vaccine market identifying the growth opportunities and competitive scenarios. The report also focuses on data from different primary and secondary sources, and is analyzed using various tools. It helps to gain insights into the market's growth potential, which can help investors identify scope and opportunities. The…
Central Nervous System (CNS) Therapeutic Market Central Nervous System (CNS) The …
MARKET INTRODUCTION
The central nervous system (CNS) is the control panel of the body, which is responsible for cognition, movement, senses and emotions. Central nervous system diseases, is a group of neurological disorders that affect the structure or function of the brain or spinal cord, which collectively form the central nervous system (CNS). The CNS diseases include neurodegenerative diseases, neurodevelopmental diseases and traumatic injuries. Drugs such as analgesics, anesthetics, nervous system…
Therapeutic Vaccines Market Insights by Top Players Novartis AG, GlaxoSmithKline …
Vaccine is a biological product that initiates stimulation to antibodies and helps provide immunity against infectious and chronic diseases. There are various types of vaccines such as inactivated vaccines, subunit vaccines, recombinant vector vaccines and DNA vaccines. Vaccines are mainly prophylactic in nature along with therapeutic effect. The wide application of vaccines is expected to favor the therapeutic vaccines market. Therapeutic vaccine is a combination of biologics that is designed…
Therapeutic Socks Market
Therapeutic Socks Market Overview
Compression therapy is a safe and cost-effective method of treating wounds, vein thrombosis, phlebitis and providing post-surgery care. It relies on a simple yet efficient principle – applying an elastic garment around a limb. A relatively new form of treatment, it is anticipated to post rapid growth during the next decade. Compression therapy includes garments like leggings, shirts, socks and stockings. The therapeutic socks market, otherwise known…
